{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:17:45Z","timestamp":1776914265924,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005242","name":"Heed Ophthalmic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1822-9","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T04:48:32Z","timestamp":1542257312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature"],"prefix":"10.1186","volume":"12","author":[{"given":"Anton M.","family":"Kolomeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"1822_CR1","first-page":"853","volume":"14","author":"JG Sebestyen","year":"1982","unstructured":"Sebestyen JG. Fibrinoid syndrome: a severe complication of vitrectomy surgery in diabetics. Ann Ophthalmol. 1982;14:853\u20136.","journal-title":"Ann Ophthalmol"},{"key":"1822_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0002-9394(81)90168-9","volume":"91","author":"CL Schepens","year":"1981","unstructured":"Schepens CL. Clinical and research aspects of subtotal open-sky vitrectomy. XXXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1981;91:143\u201371.","journal-title":"Am J Ophthalmol"},{"key":"1822_CR3","first-page":"118","volume-title":"Vitrectomy: A Pars-Plana Approach","author":"R Machemer","year":"1975","unstructured":"Machemer R. Vitrectomy: A Pars-Plana Approach. New York: Grune and Stratton Inc; 1975. p. 118."},{"key":"1822_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0886-3350(89)80109-9","volume":"15","author":"PE Walinder","year":"1989","unstructured":"Walinder PE, Olivius EO, Nordell SI, Thorburn WE. Fibrinoid reaction after extracapsular cataract extraction and relationship to exfoliation syndrome. J Cataract Refract Surg. 1989;15:526\u201330.","journal-title":"J Cataract Refract Surg"},{"key":"1822_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/112067219300300208","volume":"3","author":"S Baltatzis","year":"1993","unstructured":"Baltatzis S, Georgopoulos G, Theodossiadis P. Fibrin reaction after extracapsular cataract extraction: a statistical evaluation. Eur J Ophthalmol. 1993;3:95\u20137.","journal-title":"Eur J Ophthalmol"},{"key":"1822_CR6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/asheducation.V2012.1.88.3801172","volume":"2012","author":"A Wiestner","year":"2012","unstructured":"Wiestner A. Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Program. 2012;2012:88\u201396.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1822_CR7","first-page":"387","volume-title":"Antitargets and Drug Safety","author":"DA Keller","year":"2015","unstructured":"Keller DA, Brennan RJ, Leach KL. Antitargets and Drug Safety. In: Urban L, Patel V, Vaz RJ, editors. Antitargets and Drug Safety. Weinheim: WILEY-VCN; 2015. p. 387\u20138."},{"key":"1822_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000445119","volume":"2","author":"AC Gauthier","year":"2016","unstructured":"Gauthier AC, Nguyen A, Munday WR, Xu ML, Materin MA. Anterior chamber non-Hodgkin lymphoma of the iris masquerading as uveitis-glaucoma-hyphema syndrome. Ocular Oncol Pathol. 2016;2:230\u20133.","journal-title":"Ocular Oncol Pathol"},{"key":"1822_CR9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMc1309710","volume":"369","author":"JE Neffendorf","year":"2013","unstructured":"Neffendorf JE, Gout I, Hildebrand GD. Ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369:1277.","journal-title":"N Engl J Med"},{"key":"1822_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1400376","volume":"371","author":"JC Byrd","year":"2014","unstructured":"Byrd JC, Brown JR, O'Brien S, et al. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med. 2014;371:213\u201323.","journal-title":"N Engl J Med"},{"key":"1822_CR11","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/IAE.0b013e31828abe67","volume":"33","author":"C Luo","year":"2013","unstructured":"Luo C, Ruby A, Neuwelt M, Williams GA. Transvitreal fibrinoid pseudoendophthalmitis after diabetic vitrectomy. Retina. 2013;33:2069\u201374.","journal-title":"Retina"},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/08820538.2010.541316","volume":"26","author":"A Chiang","year":"2011","unstructured":"Chiang A, Reddy S, Tsui I, Hubschman JP. Vitreous web after pars plana vitrectomy and bevacizumab with fluid-air exchange. Semin Ophthalmol. 2011;26:25\u20137.","journal-title":"Semin Ophthalmol"},{"key":"1822_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jamaophthalmol.2015.6117","volume":"134","author":"A Thanos","year":"2016","unstructured":"Thanos A, Modjtahedi BS, Eliott D. An Unexpected Postvitrectomy Course. JAMA Ophthalmol. 2016;134:937\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"1822_CR14","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/S0886-3350(03)00075-0","volume":"29","author":"NS Jabbur","year":"2003","unstructured":"Jabbur NS. Excessive fibrin after cataract surgery associated with aminocaproic acid use. J Cataract Refract Surg. 2003;29:1636\u20137.","journal-title":"J Cataract Refract Surg"},{"key":"1822_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00164647","volume":"230","author":"K Miyake","year":"1992","unstructured":"Miyake K, Miyake Y, Maekubo K. Increased aqueous flare as a result of a therapeutic dose of mannitol in humans. Graefes Arch Clin Exp Ophthalmol. 1992;230:115\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1822_CR16","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1182\/blood-2014-06-583294","volume":"124","author":"M Levade","year":"2014","unstructured":"Levade M, David E, Garcia C, et al. Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions. Blood. 2014;124:3991\u20135.","journal-title":"Blood"},{"key":"1822_CR17","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1182\/blood-2004-04-1439","volume":"104","author":"H Brogren","year":"2004","unstructured":"Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood. 2004;104:3943\u20138.","journal-title":"Blood"},{"key":"1822_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/bjo.82.7.810","volume":"82","author":"A Heiligenhaus","year":"1998","unstructured":"Heiligenhaus A, Steinmetz B, Lapuente R, et al. Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study. Br J Ophthalmol. 1998;82:810\u20135.","journal-title":"Br J Ophthalmol"},{"key":"1822_CR19","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0161-6420(87)33278-6","volume":"94","author":"BJ Tripathi","year":"1987","unstructured":"Tripathi BJ, Geanon JD, Tripathi RC. Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study. Ophthalmology. 1987;94:1434\u20138.","journal-title":"Ophthalmology"},{"key":"1822_CR20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/jamaoncol.2015.0457","volume":"1","author":"SK Fabbro","year":"2015","unstructured":"Fabbro SK, Smith SM, Dubovsky JA, Gru AA, Jones JA. Panniculitis in patients undergoing treatment with the Bruton tyrosine kinase inhibitor ibrutinib for lymphoid leukemias. JAMA Oncol. 2015;1:684\u20136.","journal-title":"JAMA Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1822-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T19:26:52Z","timestamp":1573846012000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1822-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"3 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study conforms to the Health Insurance Portability and Accountability Act (HIPAA) and adheres to the Declaration of Helsinki and all applicable state and federal laws. Approval was not required as this is a case report of one patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"349"}}